Stock Screener App

Frei -

Installieren

3.73

1.36% 0.05

Vorhandelsmarkt: 3.75 0.02 +0.54%

Aquestive Therapeutics Inc (AQST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten

Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Investors to Inquire about Securities Investigation - ACCESS Newswire

Aquestive Therapeutics Inc (AQST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

AQST|Aquestive Therapeutics Inc|Price:3.680|Chg%:-0.090 - TradingKey

Aquestive Therapeutics Inc (AQST) Balance Sheet - TradingKey

2026-07-26 | Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Investors to Inquire about Securities Investigation | NDAQ:AQST | Press Release - Stockhouse

Aquestive Therapeutics Inc (AQST) Cash Flow - TradingKey

Aquestive Therapeutics Inc (AQST) Income Statement - TradingKey

Aquestive Therapeutics Inc (AQST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Connect - ACCESS Newswire

ETFs Investing in Aquestive Therapeutics, Inc. Stocks - TradingView

Aquestive Therapeutics Inc (AQST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Reach Out - ACCESS Newswire

2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Shareholders to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse

Price to book forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView

Enterprise value to EBITDA forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView

Price to sales forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView

Enterprise value to revenue forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView

Form 4 Aquestive Therapeutics Inc For: 17 July By Investing.com - Investing.com South Africa

Insider Sell: Aquestive Therapeutics Inc (AQST) President and CE - GuruFocus

Aquestive Therapeutics president and CEO Daniel Barber sells $100,191 in stock - Investing.com Canada

Aquestive Therapeutics (AQST) CEO Barber sells 25,000 shares between $4.00 and $4.04 - Stock Titan

Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 common shares worth $100,201.97 - Bitget

Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Aquestive Therapeutics, Inc. (AQST) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gew - The National Law Review

2026-07-16 | Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse

Enterprise value to EBIT forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, I - The National Law Review

Form 144 Aquestive Therapeutics For: 15 July By Investing.com - Investing.com South Africa

Price to earnings forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

2026-07-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Investors to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse

Aquestive Therapeutics Inc (AQST) Institutional Confidence - TradingKey

Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Aquestive Therapeutics (AQST) Faces Selling Pressure, Tests Support Near $3.91Cash Flow Strong Stocks - dars.gov.et

2026-07-12 | Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Investors to Connect - ACCESS Newswire

Aquestive Therapeutics, Inc. SEC Filing (Jul 9, 2026) - Stock Titan

Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism - Investing News Network

Aquestive Therapeutics to present at Leerink Pa... - Pluang

AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

2026-07-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Investors to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse

AQSTAquestive Therapeutics Inc Short Interest - Finviz

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Stockholders to Connect - ACCESS Newswire

AQST News | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill

Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

SEC Form S-3 filed by Aquestive Therapeutics Inc. - Quantisnow

Form S-3 Aquestive Therapeutics Inc For: 26 June By Investing.com - Investing.com India

Aquestive Therapeutics | S-3: Registration statement for specified transactions by certain issuers - Moomoo

AQST Stock Price and Chart — NASDAQ:AQST - TradingView

Cantor Fitzgerald Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $11 - Moomoo

Aquestive Therapeutics, Inc. Actuals & Estimates (NASDAQ:AQST) - TradingView

symbol__ Stock Quote Price and Forecast - CNN

AQST Forecast — Price Target — Prediction for 2027 - TradingView

LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9 - Moomoo

ALKS

$52.73

0.30%

RDY

$11.77

0.17%

ELAN

$25.41

2.01%

NBIX

$176.41

0.36%

VTRS

$17.64

2.29%

UTHR

$527.94

0.10%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters